CUSTOMER SUPPORT CUSTOMER SUPPORT 022-4603 7236

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Jan-21-2025

UTI Healthcare Fund(G)-Direct Plan

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Ltd.
11.07
Cipla Ltd.
5.75
Dr. Reddy's Laboratories Ltd.
5.28
Ajanta Pharma Ltd.
4.58
Glenmark Pharmaceuticals Ltd.
4.03
Gland Pharma Ltd.
3.83
Apollo Hospitals Enterprise Ltd.
3.54
Fortis Healthcare Ltd.
3.25
Procter & Gamble Health Ltd.
3.14
Divi's Laboratories Ltd.
3.03
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
76.43
Hospital & Healthcare Services
18.90
Business Support
1.25
Medical Equipment/Supplies/Accessories
0.73
Insurance
0.29
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 29.37 NA
Mid-Cap 25.03 NA
Small-Cap 43.19 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 23/03/20
to 23/03/21
86.35NA
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 06/04/15
to 06/04/16
-17.93NA
Ratios
Standard Deviation[%] 15.45
Sharpe Ratio [%] 0.66
Turnover Ratio [%] 0.30
Modified Duration
YTM
Riskometer
very high risk

Investors understand that their principal will be at very high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
01-Aug-05
Inception Date (Direct Plan)
01-Jan-13
Expense Ratio (Direct Plan) %
1.21
Expense Ratio (Regular Plan) %
2.23
Investing Style
Mid Growth
Fund Manager
Kamal Gada
Scheme Benchmark
BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
1,235.91
Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
UTI Healthcare Fund(G)-Direct Plan BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark